TIVC Valuation

Tivic Health Systems Inc

Add to Watchlist

Advanced Chart

3.200

0(0.000%)1D

Overview
Forecast
Valuation
Earnings

TIVC Relative Valuation

TIVC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TIVC is overvalued; if below, it's undervalued.

Historical Valuation

Tivic Health Systems Inc (TIVC) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.41 is considered Undervalued compared with the five-year average of -0.62. The fair price of Tivic Health Systems Inc (TIVC) is between 12.32 to 14.29 according to relative valuation methord. Compared to the current price of 3.19 USD , Tivic Health Systems Inc is Undervalued By 74.14%.

Relative Value

Fair Zone

12.32-14.29

Current Price：3.19

74.14%

Undervalued

0.00

Trailing

Forward

-0.36

EV/EBITDA

Tivic Health Systems Inc. (TIVC) has a current EV/EBITDA of -0.36. The 5-year average EV/EBITDA is -0.27. The thresholds are as follows: Strongly Undervalued below -1.43, Undervalued between -1.43 and -0.85, Fairly Valued between 0.31 and -0.85, Overvalued between 0.31 and 0.89, and Strongly Overvalued above 0.89. The current Forward EV/EBITDA of -0.36 falls within the Historic Trend Line -Fairly Valued range.

-0.34

EV/EBIT

Tivic Health Systems Inc. (TIVC) has a current EV/EBIT of -0.34. The 5-year average EV/EBIT is -0.17. The thresholds are as follows: Strongly Undervalued below -1.25, Undervalued between -1.25 and -0.71, Fairly Valued between 0.37 and -0.71, Overvalued between 0.37 and 0.91, and Strongly Overvalued above 0.91. The current Forward EV/EBIT of -0.34 falls within the Historic Trend Line -Fairly Valued range.

0.43

Tivic Health Systems Inc. (TIVC) has a current PS of 0.43. The 5-year average PS is 2.23. The thresholds are as follows: Strongly Undervalued below -3.69, Undervalued between -3.69 and -0.73, Fairly Valued between 5.19 and -0.73, Overvalued between 5.19 and 8.15, and Strongly Overvalued above 8.15. The current Forward PS of 0.43 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Tivic Health Systems Inc. (TIVC) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.

0.00

P/FCF

Tivic Health Systems Inc. (TIVC) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

Tivic Health Systems Inc (TIVC) has a current Price-to-Book (P/B) ratio of 0.84. Compared to its 3-year average P/B ratio of 0.87 , the current P/B ratio is approximately -3.85% higher. Relative to its 5-year average P/B ratio of 0.91, the current P/B ratio is about -7.72% higher. Tivic Health Systems Inc (TIVC) has a Forward Free Cash Flow (FCF) yield of approximately -166.23%. Compared to its 3-year average FCF yield of -254.80%, the current FCF yield is approximately -34.76% lower. Relative to its 5-year average FCF yield of -208.33% , the current FCF yield is about -20.21% lower.

0.84

P/B

Median3y

0.87

Median5y

0.91

-157.95

FCF Yield

Median3y

-254.80

Median5y

-208.33

Competitors Valuation Multiple

The average P/S ratio for TIVC's competitors is 5.80, providing a benchmark for relative valuation. Tivic Health Systems Inc Corp (TIVC) exhibits a P/S ratio of 0.43, which is -92.54% above the industry average. Given its robust revenue growth of -38.57%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

TIVC.O

Tivic Health Systems Inc

Xylo Technologies Ltd

ENDRA Life Sciences Inc

34.10

3.30M

Performance Decomposition

Market capitalization of TIVC decreased by 43.37% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -904.29 to -2.25K.

The secondary factor is the Revenue Growth, contributed -38.57%to the performance.

Overall, the performance of TIVC in the past 1 year is driven by Margin Expansion. Which is more sustainable.

-38.57%

140.00K → 86.00K

Revenue Growth

148.30%

-904.29 → -2.25K

Margin Expansion

-153.10%

0.55 → -0.29

P/E Change

-43.37%